Clinical Trial Update: Safety and Pharmacokinetics Study of a New Drug for Type 2 Diabetes [Phase 1]

View source ↗

Summary

This Phase 1 safety and pharmacokinetics study of a new drug for type 2 diabetes in healthy volunteers has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• New Drug

Snippet

Sponsor: Genmedica Therapeutics S.L. | Conditions: Healthy | Phase 1 | Status: TERMINATED